896 related articles for article (PubMed ID: 16085959)
41. Clinical Presentation and Outcomes of Kawasaki Disease in Children from Latin America: A Multicenter Observational Study from the REKAMLATINA Network.
Narayan HK; Lizcano A; Lam-Hine T; Ulloa-Gutierrez R; Bainto EV; Garrido-García LM; Estripeaut D; Del Aguila O; Gómez V; Faugier-Fuentes E; Miño-León G; Beltrán S; Cofré F; Chacon-Cruz E; Saltigeral-Simental P; Martínez-Medina L; Dueñas L; Luciani K; Rodríguez-Quiroz FJ; Camacho Moreno G; Viviani T; Alvarez-Olmos MI; Marques HHS; López-Medina E; Pirez MC; Tremoulet AH;
J Pediatr; 2023 Dec; 263():113346. PubMed ID: 36775190
[TBL] [Abstract][Full Text] [Related]
42. Prospective follow-up cardiac evaluation of children with Kawasaki disease in Northern India using the Japanese echocardiography criteria.
Kothur K; Singh S; Sharma Y; Mittal BR
J Cardiol; 2007 Nov; 50(5):299-307. PubMed ID: 18044459
[TBL] [Abstract][Full Text] [Related]
43. [Cardiovascular complications of Kawasaki disease: clinical cases].
Sica F; d'Amato E; Colapietra T; Romondia A
Pediatr Med Chir; 1995; 17(6):531-3. PubMed ID: 8668589
[TBL] [Abstract][Full Text] [Related]
44. Peripheral follicular cytotoxic T -like cells in Kawasaki disease with coronary artery aneurysms: A case report.
Xu M; Liu J; Pan L; Yang S
Medicine (Baltimore); 2020 Dec; 99(52):e23714. PubMed ID: 33350751
[TBL] [Abstract][Full Text] [Related]
45. Clinical characteristics of Kawasaki disease in Polish children: A retrospective study.
Smorczewska-Kiljan A; Marszał M; Friedman-Gruszczyńska J; Wieteska-Klimczak A; Książyk J; Jaworski M; Buda P
Kardiol Pol; 2022; 80(6):657-663. PubMed ID: 35380006
[TBL] [Abstract][Full Text] [Related]
46. Strict management of a pregnant patient with giant coronary artery aneurysm due to Kawasaki disease.
Taniguchi K; Ono H; Sato A; Kinomoto S; Tagawa N; Umehara N; Kato H; Sago H
Pediatr Int; 2015 Oct; 57(5):990-2. PubMed ID: 26171683
[TBL] [Abstract][Full Text] [Related]
47. A practical nomogram for predicting coronary thrombosis for Kawasaki disease patients with medium or large coronary artery aneurysm.
Peng Y; Cheng Z; Yi Q
Clin Exp Med; 2023 Aug; 23(4):1317-1324. PubMed ID: 36151486
[TBL] [Abstract][Full Text] [Related]
48. Kawasaki disease with giant coronary artery aneurysms.
Hedgire S; Pulli B; Lahoud-Rahme M; Beroukhim RS; Rosales AM; Ghoshhajra B
Coron Artery Dis; 2017 Mar; 28(2):177-179. PubMed ID: 27755008
[No Abstract] [Full Text] [Related]
49. Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland.
Stasiak A; Smolewska E
Rheumatol Int; 2019 Jun; 39(6):1069-1076. PubMed ID: 30903369
[TBL] [Abstract][Full Text] [Related]
50. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425
[TBL] [Abstract][Full Text] [Related]
51. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
Haiyan G; Jianming L; Suqian T; Dong Q; Shuang L; Jin Z
BMC Pediatr; 2022 Jan; 22(1):29. PubMed ID: 34996405
[TBL] [Abstract][Full Text] [Related]
52. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
Friedman KG; Gauvreau K; Baker A; Son MB; Sundel R; Dionne A; Giorgio T; De Ferranti S; Newburger JW
Arch Dis Child; 2021 Mar; 106(3):247-252. PubMed ID: 32943389
[TBL] [Abstract][Full Text] [Related]
53. Identifying Kawasaki Disease With a Low Coronary Artery Aneurysm Risk.
Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
Pediatr Infect Dis J; 2023 Jul; 42(7):608-613. PubMed ID: 37053581
[TBL] [Abstract][Full Text] [Related]
54. Kawasaki disease. Involution of giant coronary aneurysms after prolonged anti-inflammatory treatment.
Atik E; Foronda A; Bustamante LN
Arq Bras Cardiol; 2003 Sep; 81(3):265-72. PubMed ID: 14649251
[No Abstract] [Full Text] [Related]
55. [Kawasaki disease: new and important problems in cardiology].
Kato H; Ichinose E
J Cardiogr; 1983 Sep; 13(3):731-47. PubMed ID: 6678300
[TBL] [Abstract][Full Text] [Related]
56. Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?
Williams RV; Wilke VM; Tani LY; Minich LL
Pediatrics; 2002 Jan; 109(1):E4. PubMed ID: 11773572
[TBL] [Abstract][Full Text] [Related]
57. Infliximab as a novel therapy for refractory Kawasaki disease.
Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
[TBL] [Abstract][Full Text] [Related]
58. Incomplete Kawasaki disease in a patient with chronic granulomatous disease.
Muneuchi J; Ishimura M; Takada H; Hoshina T; Utsunomiya R; Ikeda K; Yamaguchi K; Ohga S; Kusuhara K; Hara T
Pediatr Int; 2010 Jun; 52(3):e134-6. PubMed ID: 20723110
[No Abstract] [Full Text] [Related]
59. Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesions.
Chbeir D; Gaschignard J; Bonnefoy R; Beyler C; Melki I; Faye A; Meinzer U
Pediatr Rheumatol Online J; 2018 Jul; 16(1):48. PubMed ID: 30021610
[TBL] [Abstract][Full Text] [Related]
60. Prescribing patterns of coronary artery aneurysm in Taiwan.
Lu CH; Fang CW; Chen HM; Fang YP; Fang CT; Huang YB; Chen CY; Liao KM; Yeh SJ
BMC Cardiovasc Disord; 2019 Aug; 19(1):188. PubMed ID: 31382884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
